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Abstract
Background: Genetic and environmental factors influence susceptibility to Crohn’s disease (CD): NOD2 is the strongest
individual genetic determinant and smoking the best-characterised environmental factor. Carriage of NOD2 mutations
predispose to small-intestinal, stricturing CD, a phenotype also associated with smoking. We hypothesised that cigarette
smoke extract (CSE) altered NOD2 expression and function in intestinal epithelial cells.
Methods and Findings: Intestinal epithelial cell-lines (SW480, HT29, HCT116) were stimulated with CSE and nicotine (to
mimic smoking) 6TNFa (to mimic inflammation). NOD2 expression was measured by qRT-PCR and western blotting; NOD2-
RIPK2 interactions by co-immunoprecipitation (CoIP); nuclear NFkB-p65 by ELISA; NFkB activity by luciferase reporter assays
and chemokines (CCL20, IL8) in culture supernatants by ELISA. In SW480 and HT29 cells the TNFa-induced NOD2 expression
at 4 hours was reduced by CSE (p=0.0226), a response that was dose-dependent (p=0.003) and time-dependent
(p=0.0004). Similar effects of CSE on NOD2 expression were seen in cultured ileal biopsies from healthy individuals. In
SW480 cells CSE reduced TNFa-induced NFkB-p65 translocation at 15 minutes post-stimulation, upstream of NOD2. Levels
of the NOD2-RIPK2 complex were no different at 8 hours post-stimulation with combinations of CSE, nicotine and TNFa, but
at 18 hours it was increased in cells stimulated with TNFa+CSE but decreased with TNFa alone (p=0.0330); CSE reduced
TNFa-induced NFkB activity (p=0.0014) at the same time-point. At 24 hours, basal CCL20 and IL8 (p,0.001 for both) and
TNFa-induced CCL20 (p=0.0330) production were decreased by CSE. CSE also reduced NOD2 expression, CCL20 and IL8
production seen with MDP-stimulation of SW480 cells pre-treated with combinations of TNFa and CSE.
Conclusions: CSE delayed TNFa-induced NOD2 mRNA expression and was associated with abnormal NOD2/RIPK2
interaction, reduced NFkB activity and decreased chemokine production. These effects may be involved in the pathogenesis
of small-intestinal CD and may have wider implications for the effects of smoking in NOD2-mediated responses.
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Introduction
The chronic inflammatory bowel diseases (IBD), Crohn’s disease
(CD) and ulcerative colitis (UC) are now common causes of
gastrointestinal disease in the UK, estimated at 1 in 250 [1]. The
aetiology of IBD is unknown, but dysregulated innate intestinal
responses to luminal bacteria are consistently implicated in animal
and human studies of disease pathogenesis [2]. Recent genome-
wide association studies identified a number of susceptibility genes
contributing to the pathogenesis of IBD [3,4]. These findings are
consistent with the model that CD and UC are related polygenic
diseases, sharing some but not all genetic determinants [5].
Nucleotide-binding oligomerization domain (NOD)2 is an intra-
cellular receptor for the bacterial motif muramyl-dipeptide (MDP)
[6]. NOD2 interacts with receptor interacting serine-threonine
kinase-2 (RIPK2, also known as RIP2, RICK or CARDIAK)
through the interaction of their CARD domains, leading to the poly-
ubiquitination of RIPK2 and activation of the transcription factor
NFkB [7]. NOD2 was the first susceptibility gene identified in CD
[8,9] and remains the strongest genetic determinant yet discovered.
Disease-associated NOD2 mutations occur in CD patients, with
associations with small bowel CD [10] and complications of stricture
and fistula formation [11,12] but not with colonic CD or UC. The
common NOD2 mutations have also found to be important in other
diseases, e.g. in bone-marrow transplant; there is some evidence that
NOD2 mutations enhance the occurrence and/or severity of
intestinal symptoms in graft versus host disease (GvHD) [13]; they
have also been shown to be important in susceptibility to leprosy
[14,15] and colorectal cancer [16].
The mechanisms whereby NOD2 mutations result in intestinal
inflammation in CD remain incompletely understood. NOD2 is
expressed by professional antigen presenting cells (APC), as well as
PLoS ONE | www.plosone.org 1 September 2011 | Volume 6 | Issue 9 | e24715a variety of other cell types. In the intestine, these include epithelial
cells, Paneth cells and goblet cells. Evidence suggests that NOD2
mutations are associated with a loss of innate immune protective
mechanisms in both circulating APC and in the intestine: e.g. loss
of cellular NOD2 expression [17] and downstream NFkB
signalling [17,18], reduction of the a-defensins from Paneth cells
[19], cytokine production [20] and intestinal epithelial cell barrier
function [21]. NOD2 has been shown to interact with the
autophagy protein, ATG16L1 (another genetic susceptibility locus
for CD [3]), in the response to bacteria [22,23]. The role of NOD2
is wider than previously thought as it has also been shown to be
expressed by neutrophils [24] and to have anti-viral responses
[25]. The relative importance of altered NOD2 signalling in
circulating APC compared with intestinal epithelial cell NOD2
signalling in the pathogenesis of CD remains a critical area for
investigation.
NOD2 in intestinal epithelial cells is important in maintenance of
barrier function against bacteria [26,21]. The immune response to
bacteria is initiated by macrophages and dendritic cells in the lamina
propriasamplingthegutlumen.Thesecellsproducepro-inflammatory
cytokines, including TNFa[27,28], which increase NOD2 expression
in nearby epithelial cells [29], suggesting that NOD2 up-regulation
with inflammation is an important and appropriate initial response
within these cells, to ‘‘prime’’ cells to increase antibacterial responses;
indeed NFkB response elements within the NOD2 promoter are
involved in increased NOD2 expression [18]. Intestinal epithelial cell
responses to muramyl-dipeptide (MDP) have been found to be more
efficient in cells pre-treated with TNFa to induce NOD2 [29].
Adherent invasive E. coli (AIEC) have been isolated from ileal CD.
These bacteria colonise epithelial cells and are also able to induce the
s e c r e t i o no fl a r g ea m o u n t so fT N F a from macrophages [26]. The
increase in expression of NOD2 in these cells leads to the production
of cytokines and anti-microbial peptides [30], also important in the
anti-bacterial response.
Apart from the bacterial environment, cigarette smoking is the
best known environmental factor to influence IBD aetiology:
smoking is associated with increased incidence and severity of CD
but prevention of development of UC [31,32]. The mechanisms
and smoke constituent(s) involved require further investigation;
only nicotine has received attention in IBD, in clinical trials or
Figure 1. TNFa-induced NOD2 and RIPK2 expression is reduced by CSE. A: Epithelial cell lines (SW480, HT29, HCT116) were stimulated with
combinations of 2% CSE (C), 100 ng/ml nicotine (N) and 50 ng/ml TNFa (T). NOD2 mRNA expression is shown in response to these stimuli as relative
expression compared with unstimulated (unstim) cells, which were given a value of 1. Results from cells stimulated with CSE alone are denoted C,
nicotine alone as N, CSE and nicotine together as CN, TNFa alone as T, TNFa and CSE together as TC, TNFa and nicotine together as TN, TNFa, CSE
and nicotine together as TCN. B: The reduction in TNFa-induced NOD2 expression is dose-dependent. SW480 cells were stimulated with T or TC at
decreasing percentage solution concentrations from 2% (TC 2%) down to 0.0625% (TC 0.0625%). NOD2 mRNA expression is shown as detailed in A.
Bars denote significant differences (post-hoc Dunn’s test T vs unstim and T vs TC 2%, p,0.01). C: Time course of TNFa-induced NOD2 expression.
SW480 cells were stimulated with T or TC for time intervals up to 8 hours. The NOD2 expression at different time-points is shown as detailed in A. D:
RIPK2 expression in SW480 cells is shown as detailed in A.
doi:10.1371/journal.pone.0024715.g001
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immune and GI mechanisms relevant to IBD [35,36]. The effects
of nicotine or other components of cigarette smoke on gut-derived
cells are poorly characterised. Nicotine levels in saliva and gastric
juice of smokers have been found to be considerably higher than
that found in blood [35], suggesting that cigarette smoke products
dissolve quickly in saliva and are swallowed. Cigarette smoke
extract (CSE) has been used as a model for the effects of smoking
in lung diseases and shown to increase production of pro-
inflammatory cytokines [37], affect apoptosis [38], neutrophil
phagocytosis [39] and mechanisms of lung repair [40,41], all of
which are relevant to the gut.
We have previously shown profound effects of smoking on
disease history in both CD and UC, whereby smoking defined the
disease location or extent and subsequent disease course [42,43].
Cessation of smoking induces a more benign disease course in CD
patients [44]. While there is no direct association between NOD2
variants and smoking habit [45], CD patients who smoke tend to
have a phenotype similar to those with NOD2 mutations:
stricturing, ileal disease [10,11,12], raising the question of whether
smoking might affect NOD2 expression or activation in intestinal
cells.
We hypothesised that constituents of cigarette smoke may have
a direct effect on innate immune activation in the intestinal
epithelium, by affecting NOD2 signalling. The primary aim of this
study was to investigate whether CSE or nicotine affected NOD2
expression in intestinal epithelial cell lines (SW480, HT29 and
HCT116) and biopsies from healthy individuals. SW480 and
HCT116 cells are known to constitutively express NOD2 [21];
NOD2 is induced in HT29 and up-regulated in SW480 cells by
TNFa, which we used to model the inflammation-induced up-
regulation of NOD2 [29]. We demonstrate that cigarette smoke
extract (CSE) was responsible for a marked inhibition of TNFa-
induced NOD2 expression, with a reduction in the early
translocation of NFkB. We also show that CSE prolonged the
NOD2-RIPK2 interaction with a concomitant reduction in NFkB
activity. CSE also inhibited chemokine production from these
cells. Treatment of cells with combinations of TNFa, nicotine and
CSE prior to stimulation with MDP also affected NOD2
expression and chemokine production. All these responses
potentially give new insight into the mechanisms behind cigarette
smoking and CD and may have wider implications for the effect of
smoking on other NOD2-mediated immune mechanisms.
Methods
Unless otherwise specified all reagents were obtained from
Invitrogen, UK.
Cigarette smoke extract (CSE) and cell stimulation
Intestinal epithelial adenocarcinoma cell lines were obtained
from the European Collection of Cell Cultures (HPACC, UK) and
grown in media containing Penicillin (100 U/ml), Streptomycin
(0.1 mg/ml), Glutamine (1 mM) and 10% Foetal Bovine serum.
SW480 cells were grown in Leibovitz L15 medium, HCT116 cells
in McCoy’s medium and HT29 cells in DMEM.
CSE was freshly made based on a method for cigarette smoke
condensate [46]. Smoke from one cigarette (Regal King-size,
containing 10 mg Tar and 0.9 mg nicotine) was bubbled through
sterile PBS (2.5 ml), and the resulting solution (denoted 100%
CSE) used to stimulate cells at a final concentration of 2%, similar
to amounts used in studies of CSE on signalling pathways [46,47].
Cells were stimulated with TNFa (50 ng/ml, Peprotech, UK) and
nicotine at 100 ng/ml (Sigma, UK) which approximated to that
found in arterial blood [35] and in cervical mucus [48], another
mucosal site distant from the lung. Unless otherwise stated, cells
were stimulated for 4 hours, harvested and stored at 280uC prior
to RNA extraction. Experiments were also carried out for
24 hours and supernatants were stored at 280uC. For some
experiments, cells were pre-treated with combinations of TNFa,
Figure 2. TNFa-induced translocation of NF-kB-p65 is reduced by CSE. Nuclear NF-kB-p65 levels were measured by ELISA in cells stimulated
with CSE (C), nicotine (N) 6 TNFa (T), as detailed in figure 1A. Results of 4 experiments are shown as percentage of the positive control (pos control).
A Friedman test showed a significant decrease in NF-kB-p65 in cells stimulated with TC compared with T and TN.
doi:10.1371/journal.pone.0024715.g002
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stimulation with MDP (L18-MDP, 1 mg/ml, Invivogen, UK) for a
further 4 or 24 hours.
Cells were stimulated with other chemicals from cigarette smoke
at concentrations previously found to affect NFkB activation:
acrolein (10 mM, Sigma, UK) [49], 4-hydroxy nonenal (HNE,
10 mM, Alexis Chemicals, UK) [50], or hydrogen peroxide (HP,
100 mM, Sigma, UK) [46]. For CSE titration experiments, SW480
cells were stimulated with TNFa alone or TNFa with CSE diluted
to 2%, 1%, 0.5%, 0.25%, 0.125% and 0.0625%. For the time-
courses SW480 cells were stimulated with TNFa 62% CSE for
0.5 and 1 hour and at hourly intervals up to 8 hours.
Ethics Statement
Ethical approval for this study was obtained from Lothian
Ethics Committee (LREC 2001/4/72, amended July 2009). All
individuals gave informed consent.
Organ culture of intestinal biopsies
Ileal biopsies were obtained from otherwise healthy individuals
(n=10) undergoing routine endoscopy for cancer surveillance due
to family history or previous polyps. The mean age of the
individuals at sampling was 48.3 years (range 23–71 years).
Smoking status was current smoker (n=2), never-smoker (n=5),
ex-smoker (n=3). One biopsy was stored as an uncultured control;
four other biopsies were cultured ex vivo in an organ culture model,
as previously described [34] and stimulated with CSE (0.5%),
TNFa (50 ng/ml), CSE+TNFa or medium only, for 24 hours.
Biopsies were harvested and stored in RNA LaterH at 280uC prior
to RNA extraction.
Quantitative RT-PCR for NOD2 and RIPK2
RNA was extracted from cells using RNeasyH kits (Qiagen,
UK). RNA (1 mg) was transcribed to cDNA using the Super-
ScriptIIIH Reverse Transcriptase cDNA kit with a 1:1 mixture of
oligo-dT20 and random hexamers as primers.
Initial PCRs for NOD2, GAPDH (housekeeping gene) and all
RIPK2 PCRs were carried out on the RotorgeneH6000 (Corbett
Research Instruments [now Qiagen], UK). PCR mix was:
EXPRESS SYBRH GreenER qPCR Supermix with premixed
ROX containing 1 mM of each primer (Sigma Genosys, UK) and
templatecDNA,withRNA-negativeandwatercontrols.Primerpairs
Figure 3. Co-immunoprecipitation and Western blot. A & B: Co-immuprecipitation. Cells were transfected with NOD2-myc and stimulated for 8
or 18 hours prior to co-IP for NOD2 and RIPK2. Representative western blots probed for NOD2-myc and RIPK2 after co-IP are shown (A). Control
denotes a co-IP using an irrelevant antibody, mock denotes sham-transfected cells and Lys denotes NOD2-myc and RIPK2 levels in lysed cells prior to
co-IP. Densitometry of NOD2 normalised against RIPK2 is shown from 3 experiments stimulated for 18 hours and expressed relative to unstimulated
cells which were given a value of 1 (B). A Friedman test of the NOD2:RIPK2 levels showed a significant difference in those cells stimulated with T, TC,
TN and TCN. C&D : Western blot. The lysates used for the co-IPs after stimulation for 8 or 18 hours were run on western blots showed similar patterns
of response to combinations of CSE, nicotine and TNFa. Representative western blot of NOD2 and b-Actin are shown for 8 and 18 hours (C). For the
18 hour experiments, densitometry normalised against b-Actin from 4 experiments (D) and is expressed as detailed in B.
doi:10.1371/journal.pone.0024715.g003
CSE Affects NOD2 Expression and NFkB
PLoS ONE | www.plosone.org 4 September 2011 | Volume 6 | Issue 9 | e24715were chosen using Primer3 and crossed exons. Primer sequences:
NOD2: forward AAGCAAGAGTCTGGTGTCCCTG, reverse
GGGGCAACAGAGTGGGTGAC;RIPK2:forwardGGGATAG-
CACCATTTCTGGA, reverseTGGCAAATTCTTCTCCTTGG;
GAPDH: forward TCATCTCTGCCCCCTCTGCT; reverse
CGACGCCTGCTTCACCACCT; qPCR cycle: 50uCf o r2m i n -
utes, 95uC for 2 minutes and 40 cycles of 95uCf o r1 5s ,6 0 uCf o r
1 minute. Initial gain optimisation and final melt-curve analysis (60u–
95uC) were included. Subsequent PCR experiments for NOD2 and
GAPDH used TaqmanH expression assays (Hs00223394_m1,
Hs99999905_m1,respectively) according to manufacturer’s protocol.
cDNAfrom SW480 cells was used as a standard curve, with the same
DNA dilutions for NOD2, RIPK2 and GAPDH. PCR quantification
used DDct method for the gene of interest (NOD2 or RIPK2) against
the normaliser gene (GAPDH). For each cell line, unstimulated cells
were used as the calibrator (assigned a value of 1); other samples’ gene
expression values were calculated relative to the expression in
unstimulated cells.
NFkB-p65 ELISA
SW480 cells were stimulated for 15 minutes with TNFa 6 CSE
or nicotine and harvested on ice. Nuclear extracts were made
using a Nuclear Extract Kit (Active Motif, Belgium). The nuclear
proteins were analysed in duplicate on an NFkB-p65 ELISA kit
(Active Motif, Belgium).
Co-immunoprecipitation for NOD2-RIPK2 interaction
Full-length wild-type NOD2 cDNA was cloned into a pCMV-
myc vector (Clontech, UK) and sequenced to check expression.
SW480 cells were transfected with plasmid DNA (5 mg), using
Lipofectamine 2000
TM. After overnight recovery, cells were
stimulated with combinations of CSE, nicotine and TNFa for 8
and 18 hours. Cells were harvested and lysed on ice for 20 minutes
in NP-40 Lysis buffer (500 ml, containing: 0.1 M NaCl [Sigma,
UK], 0.5% NP40-alternative [Calbiochem, UK], 0.5 M Hepes
pH 7.4, 0.01 M EDTA [both from Sigma, UK] and Complete
TM
protease-inhibitors[Roche, UK]). Aftercentrifugation (180006g for
15 minutes at 4uC), protein concentrations were measured and
equalised between samples. Samples were mixed overnight with
RIPK2 antibody (2 mg, Abgent, UK) and Protein G agarose beads
(Roche, UK) on an orbital mixer at 4uC. Beads (and immunocom-
plex) were collected by centrifugation and washed 3 times in PBS.
Sample buffer (20 ml, 50% 46NuPAGE LDS loading buffer, 40%
PBS and 10% 2-mercaptoethanol [Sigma, UK]) was added to the
beads and boiled for 5 minutes to dissociate immunocomplexes,
which were collected by centrifugation.
Western blotting
The immunocomplexes and initial cell lysates from the CoIP
experiments were run on NuPAGEH NovexH 4–12% Bis-Tris gels
in MOPS SDS running buffer at 200 V for 50 minutes. Proteins
were transferred onto PVDF membrane using NuPAGEH
Transfer buffer at 30 V for 1 hour. Blots were blocked overnight
in 5% milk (Marvel, Cadbury’s, UK) in PBS/0.1% Tween20 at
4uC. Primary antibodies diluted in 5% milk/PBS/0.1% Tween20
were used to probe for myc (1:100, sc40, Santa Cruz, USA),
RIPK2 (1:100, rabbit anti-human RIPK2 antibody, Abgent, UK)
and b-Actin (1:100, sc-69879, Santa-Cruz, USA) and incubated
overnight at 4uC. Secondary antibodies were used at 1:1000 for
2 hours at room temperature. Bands were visualised using ECL
reagent on photographic film. NOD2-myc, RIPK2 and b-actin
bands were quantified by densitometry. For the western blots and
CoIPs the NOD2:b-actin or NOD2:RIPK2 ratios, respectively,
were reported relative to unstimulated cells (assigned a value of 1).
Reporter Assays
The plasmids used have been described elsewhere [51]. The
NFkB construct had three NFkB binding sites, which were deleted
Figure 4. TNFa-induced NFkB activity at 18 hours is significantly reduced by CSE. Cells transfected with reporter constructs for NFkB (grey
bars) or those with the NFkB binding sites removed (DkB, white bars) were stimulated for 18 hours with combinations of CSE (C), nicotine (N) and
TNFa (T). Results (of 5 experiments) were normalised against a transfection control and NFkB activity is expressed relative to that in unstimulated
cells, which were given a value of 1. A Friedman test showed a significant different in those cells stimulated with T, TC, TN and TCN.
doi:10.1371/journal.pone.0024715.g004
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a pCMV-b-galactosidase construct (PCMV-b, Promega, UK).
Cells were co-transfected with the pCMV-b plasmid and either the
NFkBo rDkB plasmids using Lipofectamine
TM 2000. After
overnight recovery cells were stimulated with combinations of
CSE, nicotine (10 mg/ml) and TNFa, or with acrolein, HNE, or
HP 6 TNFa. After 18 hours, cells were harvested and lysed using
a reporter lysis assay kit (Promega, UK). Luciferase activity was
measured on a LB9507 Luminometer (Berthold). b-galactosidase
was measured using a b-galactosidase activity kit (Promega, UK).
NFkB activity was calculated as units of luciferase activity per unit
of b-galactosidase activity and reported relative to unstimulated
cells (assigned a value of 1).
ELISAs for CCL20 and IL8
CCL20 and IL8 were measured in culture supernatants of the
24-hour samples using matched antibody pairs (DuoSets, R&D
Systems, UK).
Statistics
Comparisons of results of different stimuli were compared by a
non-parametric, one-way ANOVA for repeated measures (Fried-
man test) or Kruskall-Wallis for biopsies. Comparison of results
across cell lines or time points used a two-way ANOVA. All
statistical tests were carried out using GraphPad Prism4H
GraphPad Software, San Diego, CA).
Results
Results from cells stimulated with CSE alone are denoted C,
nicotine alone as N, CSE and nicotine together as CN, TNFa
alone as T, TNFa and CSE together as TC, TNFa and nicotine
together as TN, TNFa, CSE and nicotine together as TCN.
CSE inhibited TNFa-induced up-regulation of NOD2
expression at 4 hours
TNFa up-regulated NOD2 expression in SW480 (mean relative
expression [RE]=5.5) and HT29 cells (mean RE=153); C, N or
CN had little effect on NOD2 expression in any cell line (fig. 1A).
Compared with T, NOD2 expression was reduced by TC (mean
RE from 5.5 to 1.3) in SW480 and HT29 cells (mean RE 115 to
10.3); TN had no effect compared with T in SW480 cells (mean
RE 5.5 to 5.5) but reduced expression in HT29 cells (mean RE
115 to 3.4). TCN reduced NOD2 expression in both SW480
(mean RE 5.5 to 1.8) and HT29 cells (mean RE 115 to 27.0,
figure 1A, two-way ANOVA for stimulus p=0.0226). There was
little change in NOD2 expression in HCT116 cells at 4 hours
regardless of the stimulus used. Because of this and the very low
constitutive NOD2 expression in HT29 cells (increasing the level
of error due to small changes in the unstimulated samples), we
used the SW480 cell line for subsequent experiments.
In SW480 cells, the reduction in TNFa-induced NOD2
expression by CSE was dose-dependent: titration of CSE from
2% to 0.0625% showed the restoration of the TNFa-induced
NOD2-response as the amount of CSE decreased (figure 1B,
Friedman test p=0.0003). Time course experiments comparing T
with TC showed that T-induced NOD2 expression was evident at
2–3 hours and peaked at 5–6 hours (figure 1C), whereas treatment
with TC at the same time points showed that the expression of
NOD2 was reduced and significantly delayed (two-way ANOVA
for time p=0.0004).
NOD2 interacts with RIPK2 to initiate NFkB activation [7].
qPCR results for RIPK2 (figure 1D, from 5 experiments) showed
that RIPK2 expression was not increased by C, N or CN. T and
TN marginally increased RIPK2 expression (mean RE was 1.3 for
both), which was not seen with TC or TCN (Friedman test
p=0.0167, post hoc test TC vs TN p,0.05).
CSE reduced translocation of NFkB p65 at 15 minutes
The NOD2 promoter contains two functional NFkB binding
sites which are involved in the TNFa-induced NOD2 expression
[18]. To investigate whether CSE or nicotine affected TNFa-
induced NFkB-p65 translocation from cytoplasm to nucleus and
thus potentially affect NOD2 expression, we used an NFkB-p65
ELISA on nuclear extracts of cells stimulated for 15 minutes.
Results are expressed as percentage of the positive control (100%,
figure 2, from 4 experiments). Unstimulated, C-o rN-treated cells
had low levels of NFkB-p65 (,25% of positive control); T- and
TN- treated cells had high levels of NFkB-p65 (110% of positive
control), whereas NFkB-p65 in TC-treated cells (80% of positive
control) were significantly lower than those of T and TN
(Friedman test, p=0.0417).
CSE increased TNFa-induced NOD2-RIPK2 co-IP complex
at 18 hours
We wished to investigate whether CSE affected NOD2-RIPK2
protein interactions. Due to the unavailability of a reliable anti-
NOD2 antibody we used cells transfected with a NOD2-myc
construct and an anti-myc antibody. We carried out co-IP
experiments after NOD2-transfection and stimulation for 8 and
18 hours. At 8 hours there was no significant difference in the
amount of NOD2-myc/RIPK2 complex in the cells treated with
different stimuli, whereas after 18 hours cells treated with T and
TN had smaller amounts of NOD2-myc/RIPK2 complex
compared with cells treated with TC and TCN (figure 3A,
representative blots of CoIPs for 8 and 18 hours; fig. 3B for
densitometry against RIPK2 for 18 hours, from 3 experiments).
For unstimulated cells and those stimulated with C, N and CN
there was little change in the amount of NOD2-myc/RIPK2
complex. At 18 hours, the relative amounts of NOD2-myc/
RIPK2 in cells stimulated with T, TC, TN and TCN were
significantly different (Friedman test, p=0.0330).
To determine whether differences in CoIP reflected differences
in protein expression, western blots were run from the same
lysates. At 8 hours after stimulation with combinations of TNFa,
CSE and nicotine, NOD2-myc protein expression was no
different. After 18 hours, although changes were not significant,
a similar pattern to that seen with mRNA was found: increased
NOD2-myc protein with T- and TN-stimulation but reduced to
background levels with TC, TCN, and no effect of C, N or CN
(figure 3C, representative blots for 8 and 18 hours; fig. 3D
densitometry against b-actin for 18 hours from 3 experiments).
Figure 5. CSE reduced basal and TNFa-induced CCL20 and IL8 production at 24 hours. Supernatants from cells stimulated with
combinations of CSE (C), nicotine (N) and TNFa (T) were harvested after 24 hours and CCL20 and IL8 were measured by ELISA. Results of 3
experiments are shown. Friedman tests showed significant differences in CCL20 and IL8 production in cells stimulated with C, N and CN against
unstimulated cells. A significant difference in CCL20 production was seen in cells stimulated with T, TC, TN and TCN. A similar pattern was shown in
for IL8 production with T, TC, TN and TCN but did not quite reach significance.
doi:10.1371/journal.pone.0024715.g005
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Reporter assays were used to assess whether CSE, TNFa and
nicotine affected NFkB activation at 18 hours. C, N and CN had
little effect on NFkB activity. TC and TCN, but not TN,
significantly reduced T-induced NFkB activity (Friedman test
p=0.0014, figure 4).
CSE reduced basal and TNFa-induced CCL20 and basal
IL8 production
To determine whether combinations of CSE, TNFa or nicotine
affected chemokine production, CCL20 and IL8 were assayed in
supernatants of cells cultured for 24 hours after stimulation. Both
CCL20 and IL8 production were significantly reduced after
stimulation with C or CN, but not N (figures 5A and B
respectively, Friedman tests p=0.0062 and p=0.0006, respec-
tively). T increased CCL20 production, which was significantly
reduced by TC and TCN, but not by TN (figure 5A, Friedman test
p=0.0330). T increased IL8 production, which was slightly but
not significantly reduced with TC but not TN (figure 5B,
Friedman test p=0.1476). There were no significant differences
in cell death with any stimulation.
CSE reduced basal and TNFa-induced responsiveness to
MDP
To determine whether pre-incubation with TNFa and/or CSE
affected NOD2 expression induced by MDP, cells were pre-
treated for 4 hours with combinations of TNFa and CSE. The
medium was changed and cells were then stimulated with MDP.
Pre-treatment with T significantly increased expression of NOD2
in response to MDP after 4 hours (Friedman test p=0.0185,
figure 6A), which was not seen with TC, TN or TCN. In parallel
cultures, CCL20 and IL8 production showed similar effects: the
increased chemokine production seen from stimulation with MDP
alone was significantly reduced by pre-treatment with C but not N
(CCL20: Friedman test p,0.0001, figure 6B; IL8: Friedman test
p=0.0006, figure 6C). Pre-treatment with T increased CCL20
production in response to MDP, which was significantly reduced
by TC and TCN but not TN (Friedman test p=0.0027, figure 6B).
Pre-treatment with T increased IL8 production in response to
MDP, which was reduced by TC and TCN but did not quite reach
significance (Friedman test p=0.0517, figure 6B).
Effect of other components of cigarette smoke
In separate experiments, cells stimulated with acrolein, HNE or
HP alone did not significantly induce or decrease NOD2 expression
at 4 hours, but did reduce TNFa-induced NOD2 expression
(Friedman test p=0.0517, figure 7A). Acrolein, HNE or HP alone
did not affect NFkB activity. Each of them reduced TNFa-induced
NFkB, but not significantly (Friedman test p=0.6489, figure 7B).
CSE reduced TNFa-induced expression of NOD2 in ileal
biopsies from healthy controls
To determine whether a similar pattern of the effects of TNFa
and CSE on NOD2 expression was seen in ileal biopsies we
cultured biopsies obtained from otherwise healthy individuals
undergoing cancer-screening endoscopy (n=10) withCSE6TNFa.
In these, both CSE and TNFa increased NOD2 expression to a
similar extent in ileal biopsies (mean RE=2.0 and 2.4, respectively,
figure 8A). CSE+TNFa had a lessereffect (mean RE=1.5). Noneof
these effects quite reached statistical significance (Kruskall-Wallis
test p=0.0630). On further analysis by smoking status, a trend was
found that ever-smokers (ex- and current smokers, n=5, figure 8B)
had lower NOD2 expression than those who had never smoked
(n=5, two-way ANOVA for smoking status p=0.0764).
Discussion
The aims of this study were to investigate the effects of CSE and
individual constituents of cigarette smoke on specific elements of
the NOD2 pathway in intestinal epithelial cells. We show
potentially important effects of CSE on NOD2 expression,
NOD2-RIPK2 interactions, NFkB activity and chemokine
production, as well as the effects on responses to MDP, all of
which are pertinent to CD pathogenesis and may have wider
implications for gut epithelial cell function. Whilst we cannot show
whether CSE acts at only one stage or at inter-related levels, we
provide compelling data to direct further studies.
NOD2 expression is known to be up-regulated in inflamed
intestinal tissue of CD patients [29] and in response to TNFa in
vitro [6,18,52]. We confirmed that NOD2 was constitutively
expressed in SW480 and HCT116 cells and inducible in HT29
cells [21,18]. In SW480 cells, we investigated the combined effects
of pre-existing inflammation (TNFa) and/or cigarette smoke on
the NOD2 response to MDP; while the time-point of 4 hours was
too short to see a significant effect of MDP alone, the increased
expression of NOD2 in cells pre-treated with TNFa within that
time-frame confirmed that TNFa increased the NOD2 expression
in response to MDP [29], a response that was negated by CSE.
This suggests that CSE may reduce appropriate inflammation-
induced responses to bacteria. Without MDP, CSE delayed the
TNFa-induced expression of NOD2 by 2–3 hours, consistent with
a decreased early TNFa-induced NFkB-p65 translocation by
CSE. A study in lung epithelial cells showed that CSE decreased
NFkB activation in response to H.influenzae [53]. Loss of NFkB
activation and NFkB-dependent gene responses against patho-
genic bacteria in the gut might be detrimental. Smoking may also
interfere with other mechanisms that also activate NFkB in the
presence of bacteria, possibly by mechanisms of oxidative stress
[54] or through toll-like receptors [55].
There is a wealth of evidence that smoking habit has a profound
effect on the aetiology and disease course of both CD [32,56] and
UC [42,57]. However, the mechanisms of these effects are unclear
and there is some debate as to how smoking affects the intestine.
While it may at first appear counter-intuitive for inhaled cigarette
smoke to affect the gut, it is highly plausible that smoke products
dissolve in swallowed saliva and thus directly affect the gut, or that
these products dissolve in blood and are carried to the gut through
the circulation where they can exert their effects. Certainly,
differences in potential mechanisms have been observed between
Figure 6. Pre-treatment with CSE and TNFa affected responses to MDP. A: SW480 cells were pre-treated with combinations of C, N and T for
4 hours before the medium was changed and cells were stimulated with MDP (1 mg/ml, denoted by +) for 4 hours. NOD2 mRNA expression is shown
in response to these stimuli as relative expression compared with unstimulated (unstim) cells, which were given a value of 1. A Freidman test showed
significantly higher NOD2 expression was seen in cells pre-treated with T. B and C: Supernatants from cells pre-treated with combinations of CSE (C),
nicotine (N) and TNFa (T) for 4 hours, prior to medium change and stimulation with MDP, were harvested after 24 hours; CCL20 (B) and IL8 (C) were
measured by ELISA. Friedman tests showed significant differences in CCL20 and IL8 production in cells pre-treated with C and N against unstimulated
cells, before MDP stimulation. A significant difference in CCL20 production was seen in cells pre-treated with T, TC, TN and TCN before MDP-
stimulation. A similar pattern was shown in for IL8 production with pre-treatment with T, TC, TN and TCN but did not quite reach significance.
doi:10.1371/journal.pone.0024715.g006
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smokers and non-smokers was demonstrated in the descending
colon of CD patients [58]. Similarly, differential DNA methylation
patterns in the rectal mucosa were seen between smokers and non-
smokers, which correlated with the presence of adenocarcinomas
[59]. These studies strongly suggest that smoking might have a
direct effect on the intestinal mucosa.
There is evidence that NOD2 is important in the maintenance
of intestinal epithelial barrier function [26,21]. NOD2 is also
important in the induction of epithelial anti-microbial peptides
[30]. In bone-marrow transplant, NOD2 has inhibitory effects on
antigen presentation cells leading to the induction of tolerance,
particularly in the gut [13]. Thus reduced NOD2 function (due to
germline NOD2 mutations) has led to loss of epithelial barrier
function, anti-microbial peptide production and GvHD
[13,21,26,30]. Similarly, reduced NOD2 expression due to
smoking may also lead to loss of NOD2 function, resulting in
the similar phenotypes in CD from NOD2 mutations and
smoking. Our data from ex vivo cultured ileal biopsies of otherwise
healthy individuals undergoing endoscopy for cancer surveillance
suggested that TNFa-induced NOD2 expression was also reduced
by CSE. The CSE effect on NOD2 expression in response to
TNFa in ileal biopsies had a similar pattern to that seen with the
intestinal epithelial cell lines. Interestingly, and in contrast to the
cell lines, there was a NOD2 response from stimulation with CSE
in the ileal biopsies. When these biopsies were separated by
smoking status (ever smokers vs. never smokers), lower NOD2
expression was seen in biopsies from those patients who had ever
smoked or still were smoking, raising the possibility that smoking
may have a long-term down-regulatory effect on NOD2
expression.
Epithelial cells act as ‘unprofessional’ antigen presenting cells,
and as such, are involved in maintaining homeostasis in the gut,
leading to production of tolerogenic signals such as IL10 [60].
There is considerable interest in the role of AIEC in the
pathogenesis of CD. Epithelial cells that express mutant NOD2
are less able to prevent colonisation by AIEC [26,21]. A recent
study in NOD2-deficient mice showed that Helicobacter hepaticus
infection induced granulomatous inflammation of the ileum,
which was prevented by restoration of a-defensin production
[61]. Thus NOD2 mutations (and by implication decreased
NOD2 expression/function through smoking) may lead to chronic
inflammation uncontrolled by tolerogenic or anti-inflammatory
signals [62]. It would be interesting and pertinent to see if CSE has
a similar response in ‘professional’ APCs, such as circulating
monocytes and tissue-derived macrophages and dendritic cells. A
recent study showed that NOD2 mutations also led to the loss of
IL10 production from macrophages and subsequent loss of
tolerogenic mechanisms [63]. A recent review of the effects of
tobacco smoke on macrophages (from lung, blood or cell lines)
found conflicting results from a large number of studies, due to
differences in preparation of the smoke products, the source of
macrophages and the bioassays used. However, in three studies of
blood-derived macrophages, smoke products induced a pro-
inflammatory response, and in nine studies of lung macrophages,
smoke inhibited or delayed the pro-inflammatory response of
macrophages to LPS or endotoxin mediated by TLR4 [55].
Surprisingly, the NOD2-RIPK2 co-IPs showed a reduced
amount of NOD2-RIPK2 complex at 18 hours from TNFa-
stimulated cells, while at 8 hours the amounts of NOD2-RIPK2
complex was little different; there was also a 3-fold induction of
downstream NFkB activity in cells stimulated with TNFa for
18 hours. Taken together, this suggests that the NOD2-RIPK2
complex had activated NFkB and dissociated. In contrast, cells
treated with TNFa+CSE had increased amounts of the NOD2-
RIPK2 complex and reduced NFkB activity, suggesting that the
NOD2-RIPK2 complex had not fully activated NFkB; this is also
consistent with the delayed NOD2 expression at mRNA level. The
western blot results showed that it was not due to differences in the
expression of NOD2-myc, but was possibly due to some
interference with the NOD2-RIPK2 interactions. The NOD2-
RIPK2 interaction leads to the polyubiquitination of NEMO, a
key component of the IKK complex with subsequent activation of
NFkB [64,7]. The mechanisms by which CSE or smoking might
interfere with these interactions, thus affecting NOD2-induced
NFkB signalling, require further in depth investigation. An
alternative mechanism consistent with these observations is that
CSE may stabilise the NOD2-RIPK2 complex, thereby prevent-
ing or retarding NFkB activation and subsequent observed
reduction in chemokine production [65]. Our data suggest that
CSE (or smoking) delays or prevents the prompt NOD2
upregulation in response to inflammatory stimuli and related
production of chemokines that could be crucial in recruitment of
inflammatory cells in the immune response to bacteria [60]. The
prolonged NOD2-RIPK2 interaction with TNFa+CSE stimula-
tion at 18 hours also suggests a delay in ‘‘turning off’’ the response,
which might also lead to the development of chronic inflamma-
tion.
TNFa-induced production of CCL20 and IL8 at 24 hours was
also reduced by CSE, but not nicotine, consistent with the patterns
of NOD2 expression and NFkB activation. While this is not direct
evidence of CCL20 and IL8 being affected by NOD2 expression,
other studies have shown that mutations in NOD2 (and hence
abnormal NOD2 expression) also led to decreased IL8 [20] and
CCL20 production [52]. Similarly, pre-treatment of cells with
TNFa and/or CSE prior to MDP stimulation also showed a
decrease in basal and TNF-induced CCL20 and decreased basal
IL8, although the effects of CSE on TNF-induced IL8 were not as
strong. This suggests that CSE may differentially affect specific
pathways involved in inflammation. CCL20 is involved in
recruiting specific subsets of dendritic cells to the Peyer’s patches
in the gut [66] and is an epithelial chemokine for Th17 cells
[67,68]; both mechanisms could be important in IBD [69]. In a
mouse model, cigarette smoke was found to increase apoptosis of
follicle-associated epithelial cells of Peyer’s Patches with increased
CCL20 production [70], whereas CCL20 levels were reduced by
cigarette smoke in bronchoalveolar lavage [71]and lung epithelial
cells, with concomitant reduced anti-microbial activity [72]. IL8 is
a chemotactic factor for neutrophils [73]; reduction of IL8 suggests
that an insufficient neutrophil response may also lead to
inadequate innate immunity to bacterial antigens. Neutrophil
recruitment and IL8 levels in small bowel injury have been shown
to be reduced in patients with CD compared with UC or healthy
controls [74]. Reduction in these chemokines in vivo and
subsequent loss of appropriate responses to e.g. AIEC would
Figure 7. Other components of cigarette smoke had no significant effect on TNFa-induced NOD2 expression and NF-kB activity. A:
NOD2 mRNA expression at 4 hours and B: NF-kB activity at 18 hours is shown for cells stimulated with other components of cigarette smoke with or
without TNFa (T). Ac denotes Acrolein, HNE denotes hydroxyl nonenal, HP denotes hydrogen peroxide. Results are expressed relative to that in
unstimulated cells, which were given a value of 1. Friedman tests showed that any differences did not reach statistical significance.
doi:10.1371/journal.pone.0024715.g007
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inflammatory reactions [26], and thus could be further mecha-
nisms by which smoking increases the susceptibility to small bowel
CD, with its associated more aggressive disease course [42].
In HT29 but not SW480 cells, nicotine also reduced the
TNFa-induced NOD2 expression. Nicotine has a variety of
effects within the GI tract [35,75] and both colonic epithelial
cells and lamina propria T cells express nicotinic acetyl choline
receptors (nAChR) [76,77]. The differences in the cell-line
responses may be due to differential expression of nAChRs,
although we have previously observed nicotine modifying LPS-
induced NFkB responses in SW480 cells (Aldhous, unpublished
data). Animal studies of IBD have shown that nicotine
exacerbates jejunal inflammation but ameliorates colonic
inflammation [78,79], suggesting that nicotine has diverse effects
according to intestinal location. Given the heterogeneity of
clinical presentation in IBD and the complex genetic architec-
ture, nicotine may modulate the expression/function of suscep-
tibility genes other than NOD2. A pilot study of nicotine enemas
in CD has given limited data as regarding safety and efficacy
[33] but further studies are required.
There are over 4000 compounds in cigarette smoke. As well as
nicotine, we investigated three compounds each previously shown
to affect NFkB activation in other experimental settings
[46,49,50]. In the present study these chemicals did not
significantly affect NFkB activity or significantly reduce TNFa-
induced NOD2 expression. This does not mean they would not
have effects under different experimental conditions. Individual
chemicals within cigarette smoke are potentially the active
compounds involved in IBD and the identification of these is
desirable as a chemical target for inhibition. Alternatively, the
identification of the pathway or mechanisms involved would also
act as a focus for therapeutic intervention. However, the
concentrations of these chemicals within smoke are hard to
ascertain and the combination of constituents may be crucial in
intestinal inflammation. With this in mind, we used CSE to keep
the relative concentrations of components of cigarette smoke
nearer to that of smoke products dissolved in saliva and swallowed
[35]. There have been few studies of CSE in the gut; a study in a
rat model of colitis showed that both CSE and nicotine reduced
inflammation, with concomitant decrease in neutrophil activity
[80]. This is consistent with our results of reduced IL8 production
with CSE. CSE is widely used in research into smoking-related
respiratory disease and shown to increase production of some pro-
inflammatory cytokines [37,81], but not others [47,82] depending
on the cell type and mode of stimulation. CSE has also been
reported to affect apoptosis [38], neutrophil phagocytosis [39] and
mechanisms of lung repair [40,41], all of which are relevant
mechanisms in the gut. Gaseous products, e.g. carbon monoxide
from cigarette smoke could also have an effect. Carbon monoxide
(CO) does not dissolve easily in water and may be less pertinent in
CSE. CO (and biliverdin) are produced by the action of heme-
oxygenase (HO-1) on heme; at low levels CO has anti-
inflammatory properties [83]. In the gut, CO has been found to
ameliorate colitis by the induction of IL10 via HO-1 [84] and may
be the route by which aminosalicylate drugs have their effect [83].
Our aim was to investigate the inflammation-induced upregula-
tion of NOD2 in epithelium, as these cells do not express NOD2
under homeostatic conditions [52]. The epithelial barrier increases
in permeability with inflammatory cytokines [85], thus increasing
access for bacteria. Decreased gut barrier function is an important
feature of IBD, but whether it is due to or causative of gut
inflammation [86] is not clear. Thus, upregulation of NOD2
within the cell might be important to increase antibacterial
responses. Indeed, another study also showed that responses to
MDP were more efficient in epithelial cells pre-treated with TNFa
to induce NOD2 [52].
In conclusion, we report that CSE reduced TNFa-induced
NOD2 expression, possibly by inhibiting upstream NFkB
translocation, that CSE affected NOD2 signalling and reduced
chemokine production. These data provide novel evidence for
potentially important mechanisms whereby smoke may affect
intestinal inflammation and modulate the phenotype of CD.
Indeed the implications and relevance of these findings may
extend widely beyond IBD as the importance of NOD2 in other
diseases processes is better understood.
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